Hamburg (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von Berenberg:
Luisa Hector, Analystin von Berenberg, stuft die Aktie des britisch-schwedischen Pharmakonzerns AstraZeneca plc (ISIN: GB0009895292,…
HAMBURG (dpa-AFX Broker) - Die Privatbank Berenberg hat das Kursziel für Astrazeneca von 12500 auf…
1. Currys rejects low-ball £700mln offer, second bid emerges Currys PLC (LSE:CURY) rejected an unsolicited £700 million takeover offer from…
19 February 2024
Acquisition of Icosavax Completed
AstraZeneca announced today the successful completion of the acquisition of Icosavax, Inc., a US-based clinical-stage…
…
NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat Astrazeneca auf "Overweight" mit einem Kursziel…
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Astrazeneca auf "Sell" mit einem Kursziel von 9900 Pence belassen. Die…
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Astrazeneca auf "Overweight" mit einem Kursziel von 13000 Pence belassen. Die…
Currys takeover bid rejected Moneysupermarket nets strong insurance earnings FTSE 100 opens lower, AstraZeneca surges 9.16am: House prices see first…
FTSE 100 up 13 points at 7,725. Currys in centre of bidding war. AstraZeneca, Rolls-Royce surge. 1.22pm: In case you missed it… easyJet founder calls…
FTSE 100 up 10 points at 7,722. Currys centre of bidding war. AstraZeneca, Rolls-Royce surge. 11.33am: AstraZeneca, Rolls-Royce lead risers AstraZeneca led...…
FTSE 100 up 21 points at 7,733. AstraZeneca, Rolls-Royce gain. Germany said to already be in recession. 3.57pm: Germany likely in recession -…
FTSE 100 up 6 points at 7,718. Currys takeover bid rejected. AstraZeneca surges. 9.50am: AstraZeneca: UBS sees sales boost from latest treatments As...…
FTSE 100 up 13 points at 7,725. Currys in centre of bidding war. AstraZeneca, Rolls-Royce surge. 2.25pm: Barclays gains on buyback reports Barclays PLC...…
Currys takeover bid rejected Moneysupermarket nets strong insurance earnings FTSE 100 opens lower, AstraZeneca surges 8.30am: AstraZeneca seen higher...…
FTSE 100 up 12 points at 7,724. Currys in centre of bidding war. AstraZeneca, Rolls-Royce surge. 12.24pm: UK-registered ship ‘at risk of sinking’ after Red...…
FTSE 100 up 6 points at 7,717. Currys takeover bid rejected. AstraZeneca surges. 10.44am: Gas slips on mild weather, oil continues to recede…
FTSE 100 up 21 points at 7,732. Currys in centre of bidding war. AstraZeneca, Rolls-Royce surge. 3.30pm: YouGov chief departs in key election year YouGov...…
19 February 2024
Tagrisso with the addition of chemotherapy approved in the
US for patients with EGFR-mutated advanced lung cancer
Approval based on FLAURA2…
19 February 2024
Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell…
19 February 2024
Tagrisso demonstrated overwhelming efficacy benefit for patients with unresectable, Stage III EGFR-mutated lung cancer in LAURA Phase III trial
First…
Toronto (www.aktiencheck.de) - Rating-Update:
BMO Capital Markets stuft die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG, London Stock…
Large-cap European firms with a global footprint and strong balance sheets have outperformed the ‘Magnificent Seven’ US stocks and are…
Anzeige / WerbungAstraZeneca unter der LupeAstraZeneca ist einer der größten Arzneimittelhersteller weltweit. Ein international renommierter Pharmakonzern, der in 1999 aus…
…
AstraZeneca PLC (LSE:AZN) faced a blow on Friday after Deutsche Bank analysts downgraded the pharmaceuticals giant on what they labelled a…
Major Indices Update: FTSE 100 drops on AstraZeneca disappointment Dow trades close to record highs Nikkei 225 scales new 34-year…
FRANKFURT (dpa-AFX Broker) - Deutsche Bank Research hat Astrazeneca nach Zahlen von "Hold" auf "Sell"…
FDA grants Fast Track to Ionis and AstraZenecas ATTR-CM treatment…
The FDA bestows a Fast Track designation to Ionis (IONS) and partner AstraZenecas (AZN) eplontersen for treating adults with transthyretin-mediated…
Eli Lilly (LLY) and AstraZeneca (AZN) announce fourth-quarter results. Novo Nordisk (NVO), Merck (MRK) and Novartis (NVS) make M&A announcements.…
AZN earnings call for the period ending December 31, 2023.…
After AstraZeneca reported lower-than-expected profit, CEO Pascal Soriot spoke with Bloombergs Anna Edwards, Kriti Gupta and Guy Johnson. (Source: Bloomberg)…
…
Hurdles in bringing drugs to market in the UK is putting pharmaceutical companies off investing, said the chief executive officer…
AstraZenecas earnings top estimates but shares fall on core operating profit drop…
Astrazeneca says Catalent deal shows importance of in-house capacity…
Frankfurt (Reuters) - Der britische Pharmakonzern AstraZeneca setzt auf gute Geschäfte mit seinem neuen RSV-Antikörper sowie seinen Krebsmedikamenten und erwartet…
CAMBRIDGE (dpa-AFX) - Ein gutes Geschäft mit Krebsmedikamenten gleicht bei Astrazeneca den Umsatzschwund mit Covid-Produkten…
…
AstraZeneca (AZN) marginally misses fourth-quarter estimates for earnings and sales. It expects revenues and EPS to increase at a low…
Having lost its number one spot on the FTSE 100 last year, AstraZeneca PLC (LSE:AZN) boss Pascal Soriot will no doubt be…
AstraZeneca invests $300 million in Maryland facility…
AstraZeneca PLC (LSE:AZN) shares have continued their underperformance from the final quarter of last year into January, with Barclays identifying three...…
…
Sales of AstraZenecas (AZN) key drugs like Imfinzi and Farxiga are expected to have been boosted by approvals in new…
…
AstraZeneca PLC (LSE:AZN) recently committed to reporting how its business impacts nature as part of annual corporate results, but next…
1 February 2024 15:00 GMT
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…
AstraZenecas (AZN) sBLA for Enhertu to treat metastatic HER2-positive solid tumors gets priority review status by the FDA. A final…